Alyce C. Katayama quoted in article “New Guidance Still Murky for 340B Drug Pricing”Modern Healthcare 08/29/15
Below is an excerpt:
Alyce Katayama, a partner at the law firm of Quarles & Brady, said the draft guidance released by the Health Resources and Services Administration prevents non-covered healthcare organizations from prescribing discounted drugs for patients referred to them by providers covered under the program.
She added that, in some ways, the agency has altered previous information it provided, adding to the ambiguity.
“Now that we have this insight as to where HRSA might go with the guidance, I think it's just going to put everyone in limbo until it is finalized,” Katayama said. “People will be concerned about what they're doing; people who might have wanted to implement new programs will put those plans on hold because they don't know how this thing will turn out.”